Comparative effectiveness study of paliperidone palmitate 6-month with a real-world external comparator arm of paliperidone palmitate 1-month or 3-month in patients with schizophrenia

• Hlavní autoři: Ibrahim Turkoz (Autor), Joshua Wong (Autor), Benjamin Chee (Autor), Uzma Siddiqui (Autor), R. Karl Knight (Autor), Ute Richarz (Autor), Christoph U. Correll (Autor)
• Médium: Kniha
• Vydáno: SAGE Publishing, 2023-09-01T00:00:00Z.
• Témata: article
• On-line přístup: Connect to this object online.

Background: The paliperidone palmitate 6-month (PP6M) long-acting injectable formulation is currently the longest dosing interval available for schizophrenia treatment. Objective: To compare treatment outcomes between a real-world external comparator arm (ECA; NeuroBlu database) and the PP6M open-la...